Value of Routine Admission Laboratory Tests to Predict Thirty-Day Mortality in Patients With Acute Myocardial Infarction

American Journal of Cardiology

Volumn 97, Issue 10, 2006, Pages 1435-1440

  Sjauw, Krischan Daniël ^a   van der Horst, Iwan Cornelis Clemens ^a   Nijsten, Maarten Willem Nicolaas ^a   Nieuwland, Wybe ^a   Zijlstra, Felix ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CREATINE KINASE; GLUCOSE; LACTATE DEHYDROGENASE;

ACUTE HEART INFARCTION; ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; CORONARY CARE UNIT; CREATINE KINASE BLOOD LEVEL; DATA BASE; FEMALE; HOSPITAL ADMISSION; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MORTALITY; POPULATION MODEL; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; THROMBOCYTE COUNT;

AGED; DIAGNOSTIC TESTS, ROUTINE; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; STATISTICS, NONPARAMETRIC; SURVIVAL ANALYSIS;

EID: 33646201391     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2005.12.034     Document Type: Article

References (20)

1. Lee K.L., Woodlief L.H., Topol E.J., Weaver W.D., Betriu A., Col J., Simoons M., Aylward P., van de Werf F., and Califf R.M. Predictors of 30-day mortality in the era of reperfusion for acute myocardial infarction. Results from an international trial of 41,021 patients. GUSTO-I Investigators. Circulation 91 (1995) 1659-1668
2. Morrow D.A., Antman E.M., Charlesworth A., Cairns R., Murphy S.A., de Lemos J.A., Giugliano R.P., McCabe C.H., and Braunwald E. TIMI risk score for ST-elevation myocardial infarction: a convenient, bedside, clinical score for risk assessment at presentation: an intravenous nPA for treatment of infarcting myocardium early II trial substudy. Circulation 102 (2000) 2031-2037
3. Marchioli R., Avanzini F., Barzi F., Chieffo C., Di Castelnuovo A., Franzosi M.G., Geraci E., Maggioni A.P., Marfisi R.M., Mininni N., et al. Assessment of absolute risk of death after myocardial infarction by use of multiple-risk-factor assessment equations. GISSI-Prevenzione mortality risk chart. Eur Heart J 22 (2001) 2085-2103
4. Granger C.B., Goldberg R.J., Dabbous O., Pieper K.S., Eagle K.A., Cannon C.P., van de Werf F., Avezum A., Goodman S.G., Flather M.D., and Fox K.A. Predictors of hospital mortality in the global registry of acute coronary events. Arch Intern Med 163 (2003) 2345-2353
5. Eagle K.A., Lim M.J., Dabbous O.H., Pieper K.S., Goldberg R.J., van de Werf F., Goodman S.G., Granger C.B., Steg P.G., Gore J.M., et al. A validated prediction model for all forms of acute coronary syndrome. estimating the risk of 6-month postdischarge death in an international registry. JAMA 291 (2004) 2727-2733
6. Barron H.V., Cannon C.P., Murphy S.A., Braunwald E., and Gibson C.M. Association between white blood cell count, epicardial blood flow, myocardial perfusion, and clinical outcomes in the setting of acute myocardial infarction. a Thrombolysis In Myocardial Infarction 10 substudy. Circulation 102 (2000) 2329-2334
7. Grzybowski M., Welch R.D., Parsons L., Ndumele C.E., Chen E., Zalenski R., and Barron H.V. The association between white blood cell count and acute myocardial infarction in-hospital mortality. findings from the National Registry of Myocardial Infarction. Acad Emerg Med 11 (2004) 1049-1060
8. Foo K., Cooper J., Deaner A., Knight C., Suliman A., Ranjadayalan K., and Timmis A.D. A single serum glucose measurement predicts adverse outcomes across the whole range of acute coronary syndromes. Heart 89 (2003) 512-516
9. Pinto D.S., Skolnick A.H., Kirtane A.J., Murphy S.A., Barron H.V., Giugliano R.P., Cannon C.P., Braunwald E., and Gibson C.M. U-shaped relationship of blood glucose with adverse outcomes among patients with ST-segment elevation myocardial infarction. J Am Coll Cardiol 46 (2005) 178-180
10. Sabatine M.S., Morrow D.A., Giugliano R.P., Burton P.B., Murphy S.A., McCabe C.H., Gibson C.M., and Braunwald E. Association of hemoglobin levels with clinical outcomes in acute coronary syndromes. Circulation 111 (2005) 2042-2049
11. Gibson C.M., Pinto D.S., Murphy S.A., Morrow D.A., Hobbach H.P., Wiviott S.D., Giugliano R.P., Cannon C.P., Antman E.M., and Braunwald E. Association of creatinine and creatinine clearance on presentation in acute myocardial infarction with subsequent mortality. J Am Coll Cardiol 42 (2003) 1535-1543
12. Yamaguchi J., Kasanuki H., Ishii Y., Yagi M., Ogawa H., Fujii S.Y., Koganei H., Okada H., Kimura H., Horie T., et al. Prognostic significance of serum creatinine concentration for in-hospital mortality in patients with acute myocardial infarction who underwent successful primary percutaneous coronary intervention (from the Heart Institute of Japan Acute Myocardial Infarction [HIJAMI] Registry). Am J Cardiol 93 (2004) 1526-1528
13. Kirtane A.J., Leder D.M., Waikar S.S., Chertow G.M., Ray K.K., Pinto D.S., Karmpaliotis D., Burger A.J., Murphy S.A., Cannon C.P., et al. Serum blood urea nitrogen as an independent marker of subsequent mortality among patients with acute coronary syndromes and normal to mildly reduced glomerular filtration rates. J Am Coll Cardiol 45 (2005) 1781-1786
14. Goldberg A., Hammerman H., Petcherski S., Zdorovyak A., Yalonetsky S., Kapeliovich M., Agmon Y., Markiewicz W., and Aronson D. Prognostic importance of hyponatremia in acute ST-elevation myocardial infarction. Am J Med 117 (2004) 242-248
15. Furman M.I., Gore J.M., Anderson F.A., Budaj A., Goodman S.G., Avezum A., Lopez-Sendon J., Klein W., Mukherjee D., Eagle K.A., et al. Elevated leukocyte count and adverse hospital events in patients with acute coronary syndromes. findings from the Global Registry of Acute Coronary Events (GRACE). Am Heart J 147 (2004) 42-48
16. Anavekar N.S., McMurray J.J., Velazquez E.J., Solomon S.D., Kober L., Rouleau J.L., White H.D., Nordlander R., Maggioni A., Dickstein K., et al. Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. N Engl J Med 351 (2004) 1285-1295
17. Timmer J.R., Ottervanger J.P., de Boer M.J., Dambrink J.H., Hoorntje J.C., Gosselink A.T., Suryapranata H., Zijlstra F., and van't Hof A.W. Hyperglycemia is an important predictor of impaired coronary flow before reperfusion therapy in ST-segment elevation myocardial infarction. J Am Coll Cardiol 45 (2005) 999-1002
18. Libby P., and Simon D.I. Inflammation and thrombosis. the clot thickens. Circulation 103 (2001) 1718-1720
19. Frossard M., Fuchs I., Leitner J.M., Hsieh K., Vlcek M., Losert H., Domanovits H., Schreiber W., Laggner A.N., and Jilma B. Platelet function predicts myocardial damage in patients with acute myocardial infarction. Circulation 110 (2004) 1392-1397
20. Elsman P., Zijlstra F., Miedema K., Hoorntje J.C., Dikkeschei L.D., Slingerland R.J., Reiffers S., de Boer M.J., and Suryapranata H. The predictive value of cumulative lactate dehydrogenase release within the first 72 h of acute myocardial infarction in patients treated with primary angioplasty. Ann Clin Biochem 41 (2004) 142-148